Bradley Theodore Hyman, M.D., Ph.D.
This page shows the publications co-authored by Bradley Hyman and Casey Maguire.
Virus vector-mediated genetic modification of brain tumor stromal cells after intravenous delivery. J Neurooncol. 2018 Sep; 139(2):293-305.
Exosome-associated AAV vector as a robust and convenient neuroscience tool. Gene Ther. 2016 11; 23(11):819.
Exosome-associated AAV vector as a robust and convenient neuroscience tool. Gene Ther. 2016 Apr; 23(4):380-92.
Mouse gender influences brain transduction by intravascularly administered AAV9. Mol Ther. 2013 Aug; 21(8):1470-1.
Efficient Gene Transfer to the Central Nervous System by Single-Stranded Anc80L65. Mol Ther Methods Clin Dev. 2018 Sep 21; 10:197-209.
CRISPR/Cas9 Mediated Disruption of the Swedish APP Allele as a Therapeutic Approach for Early-Onset Alzheimer's Disease. Mol Ther Nucleic Acids. 2018 Jun 01; 11:429-440.
Trafficking of adeno-associated virus vectors across a model of the blood-brain barrier; a comparative study of transcytosis and transduction using primary human brain endothelial cells. J Neurochem. 2017 01; 140(2):216-230.
Tailored transgene expression to specific cell types in the central nervous system after peripheral injection with AAV9. Mol Ther Methods Clin Dev. 2016; 3:16081.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.